Search results
Fact checking claims about vaccines as new COVID-19 variant emerges
Kentucky Lantern via Yahoo News· 8 hours agoIn the last month, new COVID-19 variants — known as FLiRT and part of the omicron family — emerged...
AstraZeneca pulls its COVID-19 vaccine from the European market
WSB-TV 2 Atlanta· 7 days agoLONDON — (AP) — The pharma giant AstraZeneca has requested that the European authorization for its...
Moderna’s First Vaccine Was a Big Hit. Its Second Is a Let Down
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- Moderna Inc.’s pioneering Covid shot turned the company into a nearly $200 billion...
Moderna Stock Rebounds From Its RSV Vaccine Fallout — Is It A Buy, Again?
Investor's Business Daily· 1 day agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Is This a Setback for Moderna? | The Motley Fool
The Motley Fool· 1 day agoA potential approval will also show that Moderna isn't just a one-product company and instead can build a billion-dollar respiratory vaccine portfolio,...
Moderna Announces Update on Investigational RSV Vaccine
Morningstar· 5 days agoThe FDA has informed Moderna that it is working to conclude...
Will your last COVID vaccine work against new ‘FLiRT’ variants?
WJZY via Yahoo News· 3 days agoUltimately, it depends on when you got your last dose. In fall, an updated COVID vaccine was...
US FDA pushes decision on Moderna's RSV vaccine to end of this month
Reuters via AOL· 5 days agoThe Food and Drug Administration's move prolongs the wait for Moderna's second approved product, but...
Moderna (MRNA) Falls as FDA Extends Review Time for RSV Vaccine
Zacks via Yahoo Finance· 2 days agoThe review is now expected to be completed by the end of this month. The FDA has, however, not...
Moderna's RSV Vaccine Approval Faces Setback as FDA Delays Decision
Homenewshere.com· 5 days agoModerna announced that the FDA had delayed approval of its RSV vaccine to the end of May due to...